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ABSTRACT
Background: The sentinel lymph node (SLN) concept might minimize surgical aggressiveness in gynecological oncology,
namely in cervical and endometrial malignancies. Therefore, we assessed the feasibility of SLN identification, dissection,
and harvesting by using minilaparoscopic surgical instruments in an animal model. We compared the minilaparoscopic
approach, which is known to bring important advantages, with the use of conventional laparoscopic instruments.
Methods: Two groups of 7 female pigs were enrolled in this experiment that was performed by the same surgical team.
In group A, all animals were approached by a similar minilaparoscopic surgical instrumentation, namely a 5-mm 30°
endoscope (supraumbilical port) and 3 ancillary 3.5-mm trocars. In group B, a 5-mm conventional laparoscopic instrument
set was used. The patent blue (4.0 mL) was injected on the paracervical region. The time for SLN coloring, identification,
localization, dissection, and excision, as well as complications were recorded. The sealing of the lymphatic vessels was
observed in the 2 groups. During this experiment, and for the both groups, the Trendelenburg position was kept the same,
as well as the carbon dioxide–pneumoperitoneum pressure. Finally, a laparotomy was then performed to evaluate
whether any stained SLN still remained.
Results: All endoscopic procedures were performed without major complications. SLN were identified and excised in all
animals in both groups. The SLN localization varied between animals from external iliac to preaortic regions. The surgical
times, from skin incision to SLN removal, was 28.4  5.6 minutes for minilaparoscopy and 25.3  6.8 minutes for
conventional laparoscopy (P  .36). In group B, 1 stained SLN remained and was only detected by laparotomy.
Conclusions: We confirmed the feasibility of the minilaparoscopic surgical approach for identification, dissection, and
excision of SLN, as well as for sealing the lymphatic vessels that supply the nodes. This procedure might be considered
a potentially better alternative to reduce morbidity during staging procedures for gynecological malignancies.
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CASE REPORT
INTRODUCTION
Gynecologists pioneered the laparoscopic approach to
abdominal surgical procedures. By the late 2000s, with
improvements in training and innovative adaptations of
instruments and techniques, minimally invasive ap-
proaches for gynecologic malignancies started to be used
more often.1
Cancer of the cervix is the second most common malig-
nancy in women worldwide.2 In surgically treated patients
with early cervical cancer, lymph node metastasis is the
most important risk factor for recurrence and death.3–5 On
the other hand, in developed countries, endometrial can-
cer is the most common gynecologic malignancy.2 Evalu-
ation of lymphatic spread in cervical and endometrial
cancers staging remains an ongoing area of controversy in
the field of gynecologic oncology. Traditionally, to obtain
histological diagnosis of nodal spread, the entire lym-
phatic basin draining a tumor is removed (resulting in
prolonged operation duration, increased blood loss, in-
fection, nerve injury, lymphocyst formation, vascular in-
jury, venous thromboembolism, and lower extremity
lymphedema).6,7
A sentinel lymph node (SLN) is any lymph node that
receives direct drainage from the tumor site and is iden-
tified by a procedure called lymphatic mapping. SLN bi-
opsy techniques have been developed to decrease com-
plications related to entire lymphadenectomy, to improve
detection of micrometastatic disease, and to fine-tune our
lymphadenectomy anatomic templates. SLN mapping has
been studied in cervical and endometrial cancer with
encouraging data.8–12 The best surgical approach to iden-
tify and excise the SLN (laparotomy, laparoscopy, and
robotics) is still under evaluation.13,14
Currently, efforts of laparoscopic surgeons are aimed at
further reducing the morbidity associated with minimally
invasive technology, while maintaining the same high
standard of surgical results. With a recent focus on mini-
mizing the visibility of scars, minilaparoscopy has re-
emerged as an attractive option for surgeons because it
limits tissue trauma and offers improved cosmetics.
The combination of the SLN technique and minilaparos-
copy could be an alternative to achieve the goal of a less
aggressive surgical procedure. The former is the least
invasive method to assess lymph nodes by histologic ex-
amination and the latter seems to be one of the least
invasive surgical approaches. To add the advantage of
minilaparoscopic approach to the benefit of the SLN con-
cept on an oncologic staging system, we evaluated the
feasibility of SLN excision by minilaparoscopy in a porcine
model, and we compared it with the conventional lapa-
roscopic approach.
MATERIALS AND METHODS
The aim of the study was to test, using an in vivo porcine
model, the feasibility of minilaparoscopic approach for
SLN identification, dissection, and excision using the new
3.5-mm rotating bipolar coagulator. We did the same ex-
periments in a second control group with 5-mm conven-
tional laparoscopic instruments. Animal experiments were
performed following EU Directive 2010/63/EU and the
Portuguese law for animal welfare (Dia´rio da Repu´blica,
Portaria 1005/92).
Animal Model
To accomplish the aim, 18 female pigs (Sus scrofus do-
mesticus) weighing between 35 and 45 kg were submitted
for the surgical procedure. The first 4 animals, used to
establish anatomical landmarks and technical steps, were
not included in the following protocol. Two animal
groups were formed with 7 animals each. Group A was
submitted for minilaparoscopy and group B for conven-
tional laparoscopy. Animals were randomly assigned to
groups and the animals’ mean weight was 38  2.1 kg in
group A and 38  3.2 kg in group B. All the pigs were 12
weeks of age.
Pig Preparation
All procedures were performed with the animals under
general anesthesia with endotracheal intubation and me-
chanical ventilation. The pigs had no access to food (8
hour) nor water (4 hour) before the surgical procedure.
Animals were premedicated with a combination of azap-
erone (4 mg/kg, intramuscularly [IM]), midazolam (1 mg/
kg, IM), and atropine (0.05 mg/kg, IM). Anesthesia was
induced with propofol (6 mg/kg, intravenously) and main-
tained with continuous propofol infusion (20 mg/kg/h, in-
travenously) and buprenorphine (0.05 mg/kg, IM).
Surgical Procedures
The animals were placed in exactly the same Trendelen-
burg position (25°) and immobilized. In group A, the
pneumoperitoneum (14 mm Hg) was created using a
Veress needle at a supraumbilical position, where an op-
tical trocar (30160GC; Karl Storz 6-mm trocar set; Karl
Storz, Tuttlingen, Germany) was introduced and a 5-mm
30° endoscope (26046BA; HOPKINS II forward oblique
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telescope; Karl Storz) was used to have a general view of
the abdominal cavity. After observing the pelvis, under
direct visualization, 3 3-mm ancillary trocars (30114GZL;
Karl Storz minilaparoscopy trocar set) were inserted, 1
suprapubically and 2 laterally to the epigastric arteries, in
the left and right lower abdominal quadrants, respectively.
The bladder was fixed to the anterior abdominal wall with
a TLIFT (VECTEC, Vichy, France) to get a better exposure
of the surgical field. Internal iliac vessels were visualized
followed by the identification of external iliac vessels,
aorta, and vena cava. Patent-V blue (4 mL) was injected in
the paracervical region (Spinocan 26G 120 mm; Braun,
Melsungen, Germany). A few minutes after blue injection
on the paracervical region, the lymphatic mapping was
observed, showing the colored lymphatic channels to-
ward the lymph nodes that retained the blue dye. In this
experience, 36-cm-long minilaparoscopic instruments
(Karl Storz Endoskope minilaparoscopy instruments set)
were used, choosing among graspers, cold scissors, suc-
tion/irrigation, and the recent 3.5-mm bipolar coagulator
(Karl Storz Robi).
After opening the retroperitoneum, all blue-stained lymph
nodes were classified as sentinel and were finely dissected
and excised separately with minilaparoscopic instru-
ments. Any small bleeding was immediately controlled
with the bipolar instrument that was used also for sealing
the lymphatic vessels.
The procedure time, defined as the interval between the
start of skin incisions to SLN removal, was recorded as
well as difficulties and complications at each step of the
procedure. The intraoperative complications were de-
fined as bowel, bladder, ureteral, or vascular injuries, and
an estimated blood loss  200 mL. Estimated blood loss
was estimated from the contents of suction devices.
After SLN extraction, bilateral dissection was performed to
achieve visualization of the aorta and the vena cava and,
subsequent completion of pelvic and para-aortic lymph-
adenectomy was carried out. Finally, a laparotomy was
then performed to evaluate whether there was any re-
maining SLN. After the procedure, the pigs were eutha-
nized by anesthesia overdose.
In group B, exactly the same procedure, by the same
surgical team, was performed but with 5-mm conventional
laparoscopic instruments. To avoid possible bias compar-
ing the groups, all the experiments were performed by the
same surgical team.
Data Recording
All surgical endoscopic procedures were recorded on an
advanced image and data archiving (AIDA) device from
Karl Storz. Vital and physiological parameters (heart rate,
arterial pressure, and respiratory distress) were monitored
by the research team.
Histologic Analysis
The lymph nodes were analyzed without freezing. Lymph
nodes were fixed in neutral buffered formaldehyde for 24
to 72 hours, then cut into 0.1-cm-thick slices, and embed-
ded in a paraffin block per node. Multiple sections were
prepared from each block. A set of 3 4-m-thick sections
was cut every 250 m. Sections were stained with hema-
toxylin and eosin.
Statistical Analysis
All quantitative data are presented as mean  SD. Statistical
analysis was performed using the statistical software SigmaS-
tat (version 3.5; Systat Software Inc, San Jose, California).
Figure 1. Lymphatic afferent vessels colored by blue dye after
cervical injection.
Figure 2. Lymphatic afferent vessels colored by blue dye to the
sentinel lymph node.
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Independent samples Student t test analysis was used to
compare surgical times, and statistical significance was set at
P  .05. We also present Cohen d measure of effect size,
whereby 0.2 equates to a small effect, 0.5 equates to a
medium effect, and effects  0.8 equate to large effects.15
RESULTS
Following the blue dye injection on the paracervical re-
gion, the blue lymphatic channels were identified
(Figures 1 and 2) as well as the ending blue lymph node,
which was considered the SLN. The average time for
coloring of the SLNs was 7.9 1.1 minutes in group A and
7.3  1.1 minutes in group B [t(12)  0.98; P  .35, d 
0.524 – medium effect size]. The retroperitoneum was
accessed in the standard fashion with care to avoid bleed-
ing from vessels and capillaries, which might stain the
retroperitoneum, resulting in greater difficulty in follow-
ing the blue lymphatic channels. Identification, dissection,
and excision of SLNs were performed with success in all
pigs. The overall results of our study are summarized in
Table 1. The average times to perform the experiments
were 28.4  5.6 minutes in group A and 25.3  6.8
minutes in group B [t(12)  0.94; P  .36, d  0.507 –
medium effect size]. From every animal, at least one col-
ored lymph node was excised; in some cases, 2 lymph
nodes were. Concerning the SLN locations, most of the
SLNs were found in the right iliac and left iliac vessels
regions, 3 on the promontory region, 1 on the right obtu-
rator, and 1 on the preaortic region. Lymphatic vessels
were sealed with the rotating bipolar instruments. Accord-
ing to our feedback, the minilaparoscopic bipolar dissec-
tor offered better small vessel hemostasis and a more
efficient sealing of the afferent lymphatics (Figure 3).
The colored lymph nodes were sent to histology
Table 1.
Individual Data After Patent Blue Injection and SLN Detection
Group SLN Complications Operative
Time, min
Coloring
Time, min
n Location
A: minilaparoscopy
1 8 1 Right iliac vessels 35
2 8 1 Right obturator 36
3 6 2 1 promontory; 1 right iliac vessels Bleeding 30 mL 31
4 9 1 Left iliac vessels 27
5 9 2 Left iliac vessels 22
6 8 1 Preaortic 25
7 7 1 Right iliac vessels 23
Mean  SD 7.86  1.07 28.43  5.65
B: conventional laparoscopy
1 7 1 Left iliac vessels 38
2 6 1 Left iliac vessels 16
3 8 1 Promontory 23
4 8 1 Right iliac vessels 26
5 6 1 Left iliac vessels 22
6 7 2 Right iliac vessels and left iliac vessels 24
7 9 1 Promontory 28
Mean  SD 7.29  1.11 25.29  6.75
P .35 .36
Cohen d 0.524 0.507
Abbreviation: SLN, sentinel lymph node.
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(Figures 4, 5, and 6). No major complications were
observed in our series. Neither urinary nor digestive tract
injuries were reported. There was 1 case of intraoperative
bleeding (30 mL), which was controlled by minilaparo-
scopic instruments. Minilaparoscopic port sites required
no suture closure. After the experiments, all animals were
submitted to laparotomy. In the group B, there was 1 SLN
that was only detected after laparotomy.
DISCUSSION
SLN techniques are now part of the standard treatment for
breast cancer,16 melanoma,17 and selected cases of vulvar
cancer.18 The application of the SLN concept for malig-
nancies of intra-abdominal organs is still under evaluation
and testing. SLN biopsy has been one of the most impor-
tant innovations in surgical oncology in recent years; it is
being reported as a less invasive procedure that brings
more information to clinicians.9,10
In SLN biopsy–negative patients, regional lymphade-
nectomy may no longer be a requirement, promising
fewer potential complications such as lymphedema,
lymphocysts, nerve injury, vascular injury, and venous
thromboembolism. In uterine cancers, SLN biopsy
holds the hope of more accurate identification of uter-
ine drainage and staging of the primary tumor, as well
as, potential applications in fertility-sparing surgical
procedures.19
The SLN detection rate is significantly higher through
laparoscopy than through laparotomy after vital dye
pericervical injection.13 In cervical cancer, lymphatic
mapping can be conducted by laparotomic or laparo-
scopic approaches. It would appear perfectly logical to
perform lymphatic mapping laparoscopically. The ad-
Figure 3. Minilaparoscopic sentinel lymph node identification
and dissection with 3.5-mm Robi Kelly forceps.
Figure 4. Lymph node colored in blue.
Figure 5. Excised sentinel lymph node. (Hematoxylin and eosin
4).
Figure 6. Excised sentinel lymph node. (Hematoxylin and eosin
20).
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vantages are several and obvious: first, the laparoscopic
surgical approach allows a more delicate and bloodless
dissection of the retroperitoneum; second, laparoscopy
permits magnification of the image, which facilitates
visualization of blue lymphatic vessels; and third, if
positive nodes are identified, the surgeon has the op-
portunity to end the procedure, thus avoiding radical
hysterectomy, and offer to patients chemoradiation
with minimal delay and reduced morbidity compared
with laparotomy.
Minilaparoscopy re-emerged has an even better approach
involving the use of miniaturized scopes and instruments
to further reduce perioperative morbidity and enhance
cosmetic healing.
Most surgeons have been hesitant to adopt minilaparos-
copy into their practice expressing concerns regarding the
instruments (not functional or not strong enough). Fur-
thermore, some have complained that 3-mm instruments
do not offer the same array of end-effector options or
functionality of the 5-mm instruments. Recently, minilapa-
roscopic surgical techniques have benefited from addi-
tional product development with a focus on improving
instrument strength and optics. The transition from 10- to
5-mm ports was a change from big to small, whereas the
transition from 5 to 3 mm is visible to invisible.20
During these experiments, the research team found those
thinner instruments to be very functional with no increase
in complexity. The new minilaparoscopic rotating bipolar
instrument (Figure 7) greatly facilitates a bloodless, pre-
cise tissue dissection, shortens the operation time, pre-
vents unnecessary application of intraperitoneal foreign
bodies, reduces the costs, and brings more convenience to
the surgeon.
Another advantage of minilaparoscopy is the possibility of
performing it under local anesthesia, generally with seda-
tion, thus avoiding general anesthesia complications.21 It
may be easier to schedule and reduce the costs of SLN
excision. It decreases the extent of intraoperative injury,
avoids incisional herniation, and reduces postoperative
pain.
In addition, the use of small-diameter laparoscopes and
instruments is feasible with low carbon dioxide pres-
sures,22 thereby reducing possible complications related
to pneumoperitoneum.
This is the first study that compares minilaparoscopic
versus conventional laparoscopic approaches for this type
of procedure. Further studies with larger samples, lower
carbon dioxide pressures, and local anesthesia should be
done. Also, human studies should be performed.
The minilaparoscopic approach to SLN is a promising
concept in the minimally invasive surgical domain.
CONCLUSIONS
Minilaparoscopic approach to SLN identification, dissec-
tion, and excision is a feasible and reproducible proce-
dure. Our comparative study revealed no statistically sig-
nificant time difference between the minilaparoscopic and
conventional laparoscopic procedures. With the smaller
tools, a gentle and fine dissection of the anatomical
planes, lymphatic nodes, and vessels was observed. Ad-
ditionally, better sealing of lymphatic afferent vessels that
supply the nodes was obtained.
This procedure can be considered a potentially better
alternative to reduce morbidity during staging procedures
for gynecologic malignancies.
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